Federal Court Considers "Functionally" - Limited Claims In A Biologic Case Mondaq News Alerts (registration) Both AbbVie and Janssen independently developed human antibodies against IL-12 as possible treatments for psoriasis using different techniques. AbbVie's antibody, known as J695 (briakinumab), has not received regulatory approval and is not marketed in ... Federal Court considers functional antibody claims valid and infringed |
